$ALXN

Alexion Pharmaceuticals Inc.

  • NASDAQ/NGS (GLOBAL SELECT MARKET)
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$183 ▲0.274%

Extented Hours

VOLUME

3

DAY RANGE

180.13 - 182.67

52 WEEK

0 - 182.67

Join Discuss about ALXN with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

SCAN RESULTS - BULLISH BOTTOMS $DISCA, $CHGG, $STNE, $ATVI, $PSX, $AZEK, $ETSY, $FTCH, $POSH, $UAA, $SNAP, $PFGC, $BMRN, $CAT, $BIGC, $AVLR, $RSX, $BKR, $COUP, $STNE, $LI, $LESL, $BMBL, $PTON, $IOVA, $RUBY TOPS $ATVI, $FTCH, $FVRR, $IFT, $SBH, $SONY, $YUM, $CVS, $NVST, $CAT, $SYK, $TDC, $TWLO, $RSX, $AMZN, $ALXN BEARISH $BK, $ELS, $KMX, $MCK, $NIO, $WFC, $NVDA, $TLT, $VALE, $INFY

50 Replies 12 👍 13 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Friday, July 16, 2021 Futures Up/Down % Last Dow 20.00 0.06% 34,884 S&P 500 3.25 0.09% 4,355 Nasdaq 18.50 0.12% 14,805 U.S. futures are pointing higher, looking to recover following a mixed day on Wall Street Thursday, as investors await the onslaught of quarterly earnings and the potential inflation impact it might be having on businesses while assessing Federal Reserve Chairman Jerome Powell’s repeated assurances that rising price pressures will only be temporary. Just this morning, auto supplier Autoliv ($ALV) posted a quarterly miss on the top and bottom line citing the negative effect of the semiconductor shortage and continued rise in raw material prices. Stocks finished Thursday’s session mostly lower following comments from Powell that the inflation surge the U.S. is experiencing as it recovers from the pandemic will ease or reverse over time. In Asian markets, The Nikkei Index dropped -276 points to 28,003, the Shanghai Index fell -25 points to 3,539, the Hang Seng Index inched up slightly to 28,004. In Europe, the German DAX is down a few points to 15,620, while the FTSE 100 is up a few points to 7,025. The yield on the benchmark 10-year Treasury rose Friday to 1.33%, trimming its third weekly decline. Busy morning of economic data with retail sales, Michigan confidence data and Business Inventories. Market Closing Prices Yesterday The S&P 500 Index dropped -14.27 points, or 0.33%, to 4,360.03 The Dow Jones Industrial Average rose 53.79 points, or 0.15%, to 34,987.02 The Nasdaq Composite slipped -101.82 points, or 0.70%, to 14,543.13 The Russell 2000 Index declined -12.07 points, or 0.55% to 2,190.29 Events Calendar for Today 8:30 AM ET Retail Sales MoM for June 8:30 AM ET Retail Sales MoM Ex: Autos MoM for June 10:00 AM ET Business Inventories MoM for May 10:00 AM ET University of Michigan Confidence, July-P 1:00 PM ET Baker Hughes Weekly rig count data 4:00 PM ET Net Long-term TIC Flows for May Macro Up/Down Last Nymex 0.28 71.93 Brent 0.21 73.68 Gold -6.35 1,823.15 EUR/USD -0.0007 1.1805 JPY/USD 0.35 110.18 10-Year Note +0.027 1.324% Sector News Breakdown Consumer Autoliv ($ALV) Q2 adj EPS $1.20 vs. est. $1.43; Q2 revs $2.02B vs. est. $2.12B; and cut its full-year outlook, citing the continued impact of the COVID-19 pandemic, the negative effect of the semiconductor shortage and continued rise in raw material prices; lowers year sales growth view to up 20%-22% from prior around 23% Alaska Air ($ALK) sees 2Q ASM -21% vs 2019, sees rev passengers -28% vs 2019, sees load factor 77%, sees 2Q economic fuel cost/gallon $1.90, sees CF from ops about $830Mm American Outdoor Brands Inc. ($AOUT) Q4 adj EPS $0.34 vs. est. $0.23; Q4 revs $64.5M vs. est. $65M; sees year EPS $2.02-$2.26 vs. est. $2.13; sees FY revs $280M-$295M vs. est. $284.9M; Q4 gross margin 44.4%, flat y/y American Airlines ($AAL) tells remaining 3,300 flight attendants on leave they’ll be coming back by the end of the year, plans to hire 800 to support demand Didi Global ($DIDI) shares fall -6% after China sends state officials from at least seven departments to the ride-hailing giant for cybersecurity review, as regulatory pressure intensifies Energy, Industrials & Materials Alcoa Inc. ($AA) Q2 adj EPS $1.49 vs. est. $1.37; Q2 revs rise 32% to $2.83B vs. est. $2.64B; continues to expect a strong 2021 based on continued economic recovery and increased demand for aluminum in all end markets; its aluminum segment is forecasting double digit growth on year-over-year sales of value-add products in 2021 Marten Transportation ($MRTN) 2Q EPS $0.26 vs est. $0.26 on revs $232.4Mm vs est. $238.6Mm Stevanato Group ($STVN) 32M share IPO priced at $21.00 Dow Inc. ($DOW) downgraded to Underperform from Neutral and LyondellBasell ($LYB) downgraded to Neutral from Buy at Bank America while firm upgraded Olin Corp. ($OLN) to Buy and Westlake Chemical ($WLK) to Neutral in chemical sector Financials Square ($SQ) is forming a new business that pulls together Seller, Cash App & Tidal to focus on “building an open developer platform with the sole goal of making it easy to create non-custodial, permissionless, and decentralized financial services,” CEO Jack Dorsey tweeted State Street ($STT) raises quarterly dividend 10% to 57c from 52c, authorizes $3B share buyback BancFirst ($BANF) Q2 EPS $1.45 vs. est. $1.13; Q2 loan loss provision ($9.9M) vs. $19.3M for 2Q20; Q2 net charge-offs were 0.06% of average loans, compared to none in 2Q20 People’s United Financial ($PBCT) 2Q adj EPS $0.41 vs. est. $0.35; NII $380.9Mm vs. est. $396.4Mm; Net interest margin 2.70% vs. 3.05% y/y; return on average assets 1.07% vs. 0.58% y/y; return on average equity 14.7% vs. 8.10% y/y; net charge-offs ratio 0.1% vs. 0.08% y/y Western Alliance Bancorp ($WAL) Q2 EPS $2.17 vs. est. $1.96; Q2 revs $506.5M vs. est. $494M; Q2 net interest income was $370.5M, an increase of $53.2M from $317.3M I Q1 Bit Digital ($BTBT) files $500M mixed securities shelf Bridge Investment $(BRDG)75M share IPO priced at $16.00 Healthcare Moderna Inc ($MRNA) will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals ($ALXN) which is being acquired by AstraZeneca ($AZN) FibroGen ($FGEN) announced that the U.S. FDA Cardiovascular and Renal Drugs Advisory Committee voted to recommend not approving Roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase Erasca ($ERAS)5M share IPO priced at $16.00 Imago BioSciences ($IMGO)6M share IPO priced at $16.00 Mesoblast ($MESO) presents clinical outcomes from remestemcel-L trial in ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS). TScan Therapeutics ($SCAN)67M share IPO priced at $15 Alexion ($ALXN) announces positive topline results from phase 3 study of Ultomiris in adults with generalized myasthenia gravis (gmg); co says study met primary endpoint of change from baseline in the myasthenia gravis-activities of daily living profile total score at week 26 Corvus Pharmaceuticals ($CRVS) discontinues phase 3 study of Mupadolimab (anti-cd73) for covid-19 due to vaccine effectiveness in reducing hospitalizations; reduces projected 2021 net cash used in operating activities by an estimated $11 mln Technology, Media & Telecom Intel ($INTC) is considering a deal to buy GlobalFoundries, The Wall Street Journal reported citing people familiar with the matter, saying a deal may value GlobalFoundries at about $30B https://on.wsj.com/3koWMam Tencent Music ($TME) downgraded to Equal Weight from Overweight at Morgan Stanley Aehr Test Systems ($AEHR) Q4 adj EPS $0.04 vs. est. $0.02; Q4 revs $7.6M vs. est. $7.03M; guides FY revs to $28M AT&T ($T), commenting in a filing, reports prelim 2Q DirecTV churn 1.87% vs 2.42% y/y; DirecTV, AT&T TV and U-Verse TV, prelim 2Q aggregate premium video gross additions 492,000, +2% y/y; DirecTV, AT&T TV and U-Verse TV, prelim 2Q video net losses 473,000, improvement of 47% y/y Blend ($BLND) 20M share IPO priced at $18.00

90 Replies 11 👍 11 🔥

profile
@Sini #Trading Nuggets
recently

$MRNA will replace $ALXN in S&P 500

128 Replies 12 👍 15 🔥

profile
@dros #droscrew
recently

Moderna (MRNA) will replace Alexion Pharmaceuticals (ALXN) in the S&P 500 Index on July 21, S&P Dow Jones Indices said Thursday.

147 Replies 6 👍 10 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, July 12, 2021 Futures Up/Down % Last Dow -182.00 0.52% 34,569 S&P 500 -12.25 0.29% 4,347 Nasdaq 34.50 0.23% 14,845 Stock futures looking mixed to start the week as the Nasdaq Comp is pointing higher while the Dow and S&P 500 look to open lower as investors turn their attention to second-quarter earnings season starting this week in order to gauge whether corporate profitability can support equity valuations. In corporate news, Virgin Galactic ($SPCE) announced that VSS Unity “successfully” reached space, completing the company’s fourth rocket-powered spaceflight, and sending shares higher. Items to watch during the week outside of earnings include the latest figures on inflation and growth. The June consumer price index will be published tomorrow, while the producer price reading will be announced on Wednesday. Also, Fed Chair Jerome Powell is also due to give his semiannual monetary policy report before the U.S. House and Senate on Wednesday and Thursday Stocks posted big gains on Friday, helping major averages close out the week in positive territory as the S&P 500 rose 0.36% the last 5-days, the Dow added 0.24%, and the Nasdaq gained 0.43% as top indices major averages cement their third-straight weekly gain. The big news last week was the precipitous drop in Treasury yields, dropping 8-straight days before having its streak snapped Friday, a day after the 10-year hit 5-month lows of 1.25%. All three indexes are heading toward closing highs, just a few days after notching the worst daily drop since June 18th mid-week. The declines had been at least partly inspired by worries about the economic recovery amid the spread of the delta variant of COVID-19. In Asian markets, The Nikkei Index surged over 600 points or 2.25% to settle at 28,569. the Shanghai Index climbed 23 points to 3,547 and the Hang Seng Index advanced 170 points to 27,515. In Europe, the German DAX is down roughly -25 points to 15,660, while the FTSE 100 is looking lower about -50 points to 7,075. Mainland China stocks gain even after Beijing tightens rules for foreign IPOs and Washington adds Chinese firms to its economic blacklist Market Closing Prices Yesterday The S&P 500 Index gained 48.73 points, or 1.13%, to 4,369.55 The Dow Jones Industrial Average rose 448.26 points, or 1.30%, to 34,870.16 The Nasdaq Composite jumped 142.12 points, or 0.98%, to 14,701.92 The Russell 2000 Index advanced 48.32 points, or 2.17% to 2,280.00 Earnings Calendar: Earnings Before the Open: none Earnings After the Close: $SLP, $VOXX Other Key Events: China Imports, Export and Trade Balance data for June Macro Up/Down Last Nymex -1.12 73.44 Brent -1.07 74.48 Gold -7.75 1,800.55 EUR/USD -0.0022 1.1854 JPY/USD -0.03 110.11 10-Year Note -0.02 1.336% Sector News Breakdown Consumer Didi Global Inc ($DIDI) shares fall -4%; on Monday confirmed the country’s cyberspace administration notified app stores to remove the ride hailing company’s 25 apps and said the move could impact its China revenue Malibu Boats ($MBUU) mentioned favorably in Barron’s saying the stock is looking ready to power through, noting buying a boat this summer has been futile for many shoppers as dealers have been sold out for months. Says even if sales cool off, Malibu should sustain growth, bolstered by market-leading brands, lean manufacturing, and innovative technologies fueling demand Energy, Industrials and Materials Virgin Galactic’s ($SPCE) VSS Unity successfully completed its flight into space with company founder Richard Branson on board, making him the second-oldest person to fly in space, and beating out Amazon ($AMZN) founder Jeff Bezos, who’s scheduled to fly in Blue Origin’s New Shepard ship on July 20. Stephen R. Rizzone to retire as president and CEO of Energous Corporation ($WATT); has also relinquished his seat on company’s board of directors; CEO search has been initiated and both internal and external candidates are being considered Tudor Perini ($TPC) subsidiary Lunda Construction Team awarded $220 Million I-70 Missouri River Bridge design-build project Credit Suisse analyst expects steel stocks to stay hot on the view that their upcycle will linger according to Barron’s, noting that may be good news for United States Steel ($X), Cleveland-Cliffs ($CLF), Steel Dynamics ($STLD), Graftech International ($EAF) and Nucor ($NUE) Financials Citigroup ($C) a positive mention in Barron’s ahead of earnings this week for the large cap banks saying JPMorgan ($JPM), Goldman Sachs ($GS), and others are expected to report, but investors shouldn’t get their hopes up. Says few are as cheap as Citigroup (C$) Through a wholly-owned subsidiary NBTC Limited, The9 Limited ($NCTY) has signed a cryptocurrency mining hosting agreement with Russian company BitRiver Healthcare AstraZeneca ($AZN) mentioned positively in Barron’s saying investors should remember that AstraZeneca is not just a vaccine company, it has a strong pipeline, a growing number of $1 billion blockbuster drugs and, with EU and U.S. approval of its acquisition of Alexion Pharmaceuticals (ALXN), a promising new rare-diseases division Celldex Therapeutics ($CLDX) updated early-stage trial data for CDX-0159, indicating 95% complete response following a single dose in patients with two most common forms of chronic inducible urticaria, a skin condition FDA chief Janet Woodcock has called for a federal investigation into the approval of Biogen’s ($BIIB) controversial Alzheimer’s drug, Aduhelm, asking the independent Office of Inspector General to look into how regulatory staffers interacted with Biogen leading up to the June 7 approval of the drug – WSJ Sinovac Biotech Ltd. ($SVA) said it will provide up to 380 million doses of its CoronaVac Covid-19 vaccine through Covax, a facility for supplying vaccines to poorer nations, as part of an advance purchase agreement with Gavi, the Vaccine Alliance. Technology, Media & Telecom Some Chinese stocks are starting to look like bargain after a wave of regulatory measures has created the type of uncertainty that draws bargain hunters, according to Barron’s Technology giants like Alibaba Group ($BABA), whose shares are down 11% this year, are popping up on value managers’ radars but caution is warranted, especially for investors in U.S.-listed shares of Chinese companies saying volatility is likely, with investors recalibrating growth expectations as Beijing rolls out new rules, and reviews past deals, the publication says AMC Entertainment ($AMC), Cinemark ($CNK): Walt Disney Co.’s ($DIS) “Black Widow” grossed $80 million in the U.S. and Canada, according to preliminary studio estimates, building on the recent success of the latest “Fast & Furious” film, “F9: The Fast Saga,” two weeks ago which grossed $70 million in its opening weekend. IMAX Corporation ($IMAX) soared to a $12 million debut for Marvel Studios’ “Black Widow,” reaching its highest grossing opening weekend of the pandemic era in 11 markets worldwide, including North America China’s market regulator on Saturday said it decided to block Tencent Holdings ($TCEHY) plan to merge the country’s top two videogame streaming sites, Huya ($HUYA) and DouYu ($DOYU) on antitrust grounds. The State Administration of Market Regulation said the decision was made after reviewing additional concessions proposed by Tencent for the merger Charter Communications ($CHTR) downgraded to Market Perform from Outperform at Bernstein @everyone

43 Replies 10 👍 12 🔥

profile
@Carlos-carvan58 #ivtrades
recently

1,000 $ALXN 100 21 MAY 21 170 CALL @4.50 LMT

131 Replies 8 👍 6 🔥

profile
@Carlos-carvan58 #ivtrades
recently

$ALXN to $175

68 Replies 10 👍 7 🔥

profile
@Pyrognosis #droscrew
recently

so that Nov ALXN would have been filled for December

73 Replies 11 👍 15 🔥

profile
@Navneet #droscrew
recently

i mean that Nov $alxn flow

115 Replies 6 👍 8 🔥

profile
@Carlos-carvan58 #ivtrades
recently

$alxn to $175

79 Replies 12 👍 12 🔥

profile
@RedSunCap #droscrew
recently

out ALXN at 35 in at 12 > @Pyrognosis said: Seems the NOV $ALXN flows were early

96 Replies 8 👍 8 🔥

profile
@Pyrognosis #droscrew
recently

Seems the NOV $ALXN flows were early

106 Replies 7 👍 9 🔥

profile
@Carlos-carvan58 #ivtrades
recently

God morning $ALXN upgraded $175/$194

94 Replies 13 👍 8 🔥

profile
@dros #droscrew
recently

ALXN Nov $130 Cs hawt

80 Replies 12 👍 10 🔥

profile
@RedSunCap #droscrew
recently

973 $ALXN Nov20 130 calls trade 3.50

94 Replies 11 👍 11 🔥

profile
@RedSunCap #droscrew
recently

973 $ALXN Nov20 130 calls trade 3.50

102 Replies 10 👍 15 🔥

profile
@RedSunCap #droscrew
recently

this $ALXN might pop out of it range

150 Replies 11 👍 9 🔥

profile
@RedSunCap #droscrew
recently

got filled on ALXN exit on the pop

79 Replies 11 👍 8 🔥

profile
@dros #droscrew
recently

yeah I like that ALXN a lot too

64 Replies 11 👍 7 🔥

profile
@RedSunCap #droscrew
recently

159 $ALXN Jan21 115 calls trade 7.69

131 Replies 6 👍 10 🔥

profile
@RedSunCap #droscrew
recently

159 $ALXN Jan21 115 calls trade 7.69

107 Replies 8 👍 15 🔥

profile
@RedSunCap #droscrew
recently

465 $ALXN Jan21 115 calls trade 8.00

65 Replies 12 👍 11 🔥

profile
@RedSunCap #droscrew
recently

465 $ALXN Jan21 115 calls trade 8.00

89 Replies 7 👍 10 🔥

profile
@RedSunCap #droscrew
recently

big fan of these ALXN calls

130 Replies 13 👍 15 🔥

profile
@RedSunCap #droscrew
recently

alxn jan 115s

112 Replies 10 👍 7 🔥

profile
@Carlos-carvan58 #ivtrades
recently

nice $ALXN today

127 Replies 15 👍 13 🔥

Key Metrics

Market Cap

0

Beta

0

Avg. Volume

0

Shares Outstanding

221.02 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

CEO: Ludwig Hantson

Website:

HQ: 121 Seaport Blvd Boston, 02210-2050 Massachusetts

Related News

  • Seeking Alpha

    ICER finds Alexion''s Soliris lacks cost-effectiveness for myasthenia gravis

    22 Jul 2021, 14:09
  • CompanyNewsHQ

    Acquisition of Alexion completed

    21 Jul 2021, 18:43
  • GuruFocus

    Samson Rock Capital LLP Buys Proofpoint Inc, Alexion Pharmaceuticals Inc, Nuance Communications ...

    20 Jul 2021, 20:38
  • Benzinga

    Alexion''s Ultomiris Sales Almost Doubles In 1H 2021 As $39B AstraZeneca Deal Looms

    20 Jul 2021, 18:37
  • GuruFocus

    BCK Capital Management LP Buys Kansas City Southern, IHS Markit, Willis Towers Watson PLC, ...

    20 Jul 2021, 12:38